Related Experiment Video
Updated: Jun 7, 2026
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Dendritic-cell tumor vaccines
1Department of Clinical Immunology, Medical University of Lublin, Clinic Hospital SPSK-4, Lublin, Poland. jacek.rolinski@gmail.com
Abstract:
Most cancers remain incurable. Introduction of novel therapeutic methods, including new cytostatic regimens and targeted therapies, such as monoclonal antibodies and tyrosine kinase inhibitors, have increased remission rates as well as improved patient survival, but the ability to cure many cancer patients remains elusive. It is thus necessary to further develop alternative strategies to improve patient prognosis. The majority of patients who respond to induction therapy inevitably relapse, mainly because of the proliferation of residual malignant cells that have escaped control by induction chemotherapy. Therefore the eradication of minimal residual disease may be crucial to prevent a relapse and achieve a long-term remission. It seems that an advantageous treatment option may be cellular immunotherapy with dendritic-cell vaccines which might induce long-term specific anticancer responses with immune memory cells, which could contribute to effective and lasting elimination of malignant cells.
Insights
Dendritic-cell vaccines offer a promising strategy for cancer immunotherapy by inducing long-term anticancer immune responses. This approach aims to eradicate minimal residual disease and prevent cancer relapse for improved patient survival.
Area of Science:
- Oncology
- Immunology
- Cancer Therapy
Background:
- Despite advances in cytostatic and targeted cancer therapies, many cancers remain incurable.
- Relapse is common due to residual malignant cells evading initial treatment.
- Eradicating minimal residual disease is critical for achieving long-term remission.
Purpose of the Study:
- To explore alternative strategies for improving cancer patient prognosis.
- To investigate the potential of cellular immunotherapy for overcoming treatment resistance.
Main Methods:
- The study focuses on the potential of dendritic-cell vaccines in cancer treatment.
- This approach leverages the immune system to target and eliminate cancer cells.
Main Results:
- Dendritic-cell vaccines may induce specific, long-term anticancer immune responses.
- This immunotherapy has the potential to generate immune memory cells.
Conclusions:
- Cellular immunotherapy with dendritic-cell vaccines presents a viable strategy for lasting cancer elimination.
- This approach could significantly improve long-term patient outcomes by targeting residual disease.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
01:51Vaccinations